m-Tolylsulfanyl-acetic acid methyl ester, 99.0%, 25g

7-AMINO-5-BROMO-1H-INDAZOLE, 95.0%, 1g

Ethyl phenoxyacetate, 99.0%, 10g

Val-Cit-PAB-OH, 98.0%, 25g

Methyl-(R)-pyrrolidin-3-yl-carbamic acid tert-butyl ester, 98.0%, 10g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylhept-6-enoic acid, 95.0%, 1g

Ethyl 2-(1-carbamoylpiperidin-4-yl)acetate, 97.0%, 250mg

(2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)oxy)butanoic acid, 97%, 50mg

(s)-2-Amino-2-(4-ethoxyphenyl)ethan-1-ol, 98%, 50mg

Imino(4-methoxyphenyl)(methyl)-lambda6-sulfanone, 98%, 500mg

(+)-4,5-Bis[hydroxy(diphenyl)methyl]-2,2-dimethyl-1,3-dioxolane>97.0%(HPLC)1g

Embouts distributeurs Ritips® évolution Bioclean®, 1 ml, 20-100 µl, 100 pièces

Bis(cyclooctadiene)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenyl)borate, 98%, 100mg